HRSA Strikes Three Off List of Drugmakers Denying 340B Pricing on Orphan Meds

by Admin | April 2, 2015 2:54 pm

April 2, 2015—The Health Resources and Services Administration has removed three drugmakers from its list of those that do not provide 340B pricing on orphan drugs to rural and cancer hospitals.  

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[1].    Already registered? Click here to login[2]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:
  1. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  2. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2015/04/hrsa-strikes-three-off-list-of-drugmakers-denying-340b-pricing-on-orphan-meds/

Copyright ©2026 340binformed.org unless otherwise noted.